Details of the Drug

General Information of Drug (ID: DM529QO)

Drug Name
pbi-shRNA STMN1
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Breast cancer 2C60-2C65 Investigative [2]
Drug Type
Short hairpin RNA
Cross-matching ID
TTD ID
DSE59Z
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
STMN1 messenger RNA (STMN1 mRNA) TT7W5OT STMN1_HUMAN Inhibitor [3]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT01505153) Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer. U.S. National Institutes of Health.
2 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
3 Clinical pipeline report, company report or official report of Gradalis.